Search - tctmd.com

Displaying 241 - 260 of 264

Sort: Relevancy | Date

News Daily News

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

October 04, 2013

Presentation

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

Presenter: Ziad Hijazi

October 02, 2013

News Conference News ESC 2013

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

Caitlin E. Cox

September 03, 2013

News Daily News

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

August 30, 2013

Presentation

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

Presenter: David Garcia

August 05, 2013

Presentation TVT 2013

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

Presenter: Josep Rodes-Cabau

June 12, 2013

News Daily News

Stroke After STEMI Unusual But Carries Poor Prognosis

Yael L. Maxwell

May 03, 2013

News Daily News

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Caitlin E. Cox

May 03, 2013

Presentation ECHO 2013

Advanced TEE: Clinical Decision Making in Cryptogenic Stroke and Atrial Fibrillation

Presenter: Marco R. Di Tullio

April 04, 2013

News Daily News

SYNTHESIS Expanded: Endovascular Treatment No Better Than IV tPA for Acute Stroke

February 07, 2013

News Daily News

Study Explores Predictors, Consequences of Stroke After TAVR

Caitlin E. Cox

November 18, 2012

Presentation TCT 2012

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Presenter: Jonathan Halperin

October 25, 2012

Presentation TCT 2012

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

Presenter: Vivek Reddy

October 24, 2012

Presentation TCT 2012

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Presenter: Michael Ezekowitz

October 24, 2012

News Daily News

Risk Score Predicts Stroke or Death in Carotid Stenting Candidates

Jason Kahn

September 28, 2012

Presentation

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Presenter: S.R. Gangireddy

September 26, 2012

News Daily News

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Caitlin E. Cox

July 12, 2012

Presentation

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Presenter: S. Lee

July 11, 2012

Presentation

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

Presenter: Corey S. Miller

May 03, 2012

News Daily News

PFO-Stroke Link Takes Another Hit

Jason Kahn

August 11, 2011

Advertisement

Troponin T Improves Clinical Stroke Risk Assessment in A-fib Patients

High Sensitivity Troponin T and Risk Stratification in Patients with A-fib on Apixaban or Warfarin

New Alternatives Match Efficacy to Warfarin in High-Risk Subgroups

PFO Increases Stroke Risk After Endovascular Device Lead Implantation

Apixaban Vs. Warfarin in Patients with Atrial Fibrillation According to Prior Warfarin Use

Predictors of TAVR: Associated Strokes: New Onset Atrial Fibrillation, Postdilatation, and Others

Stroke After STEMI Unusual But Carries Poor Prognosis

GPIs Superior for Rescue Treatment after Endovascular Coiling for Cerebral Aneurysm

Advanced TEE: Clinical Decision Making in Cryptogenic Stroke and Atrial Fibrillation

SYNTHESIS Expanded: Endovascular Treatment No Better Than IV tPA for Acute Stroke

Study Explores Predictors, Consequences of Stroke After TAVR

Novel Anticoagulants for Stroke Prevention in Patients with Atrial Fibrillation

Does Atrial Fibrillation Ablation Reduce Cardioembolic Stroke?

Anticoagulation Choices for Atrial Fibrillation: Which Drug for Which Patient?

Risk Score Predicts Stroke or Death in Carotid Stenting Candidates

Percutaneous LAA Closure for Stroke Prevention in A-fib Patients: An Assessment of Net Clinical Benefit

Apixaban Less Costly Than Aspirin for Stroke Prevention in A-Fib at 10 Years

Cost-Effectiveness of Apixaban vs. Aspirin for Stroke Prevention Among A-fib Pts Unsuitable for Warfarin

Meta-Analysis of Efficacy and Safety of New Oral Anticoagulants (Dabigatran, Rivaroxaban, Apixaban) vs. Warfarin in Patients with A-fib

PFO-Stroke Link Takes Another Hit

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content